Patents
Patents for C07J 43 - Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,516)
09/2001
09/26/2001EP0528991B1 Detectably labelled marker component comprising a fluorophore moiety , fluorescent probe comprising the marker component and uses thereof.
09/20/2001WO2001018025A3 17alpha propynyl 11-aryl steroids
09/19/2001CN1313862A Novel 17-halogenated 19-Nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
09/07/2001WO2001064708A1 Bile acids conjugates with metal ion chelates and the use thereof
08/2001
08/29/2001CN1310721A Medicine nitrate salts
08/28/2001US6281205 Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
08/28/2001US6281204 19-nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, and the intermediates of this process, their use as medicaments and compositions
08/21/2001US6277838 Methods for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
08/07/2001US6271403 7α-(xi-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7α-(xi-aminoalkyl-estratrienes as well as their use for the production of pharmaceutical agents
07/2001
07/26/2001WO2001053355A1 An in vivo screen using chemical inducers of dimerization
07/26/2001CA2398010A1 An in vivo screen using chemical inducers of dimerization
07/25/2001EP1117676A1 Propanolamine derivatives linked with bile acid used for treating disorders of the lipid metabolism
07/24/2001US6265558 Compound of linked nucleosides having thiol group attatched at 5-pyrimidine or 2-, 6-, or 8-purine positions; attachment reporter molecules, reporter enzymes, steroids, lipophilic molecules, peptides, proteins and other groups
07/19/2001US20010008936 Oligonucleotides having chiral phosphorus linkages
07/17/2001US6262241 Antisense compounds which cleave phosphorodiester bonds and improve pharmacodynamic and pharmacokinetic properties of oligonucleotides, useful in diagnosing diseases
07/17/2001US6262042 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
07/11/2001CN1303391A 17 Beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
07/11/2001CN1068333C Sterol derivatives used as regulation of meiosis
07/10/2001US6258792 Cationic cholesteryl derivatives containing cyclic polar groups
06/2001
06/26/2001US6251939 Carbamate-based cationic lipids
06/14/2001WO2001042273A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/14/2001US20010003782 Novel sterol derivatives used for regulating the meiosis in oocytes and in male germ cells
06/13/2001EP1105408A1 Congugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents
06/07/2001WO2001040805A1 Steroid compounds for steroid receptor binding assays
06/06/2001CN1298409A 20-keto-11&beta, -arylsteroids and their derivatives having agonist or antagonist hormonal properties
06/05/2001US6242592 Process for the preparation of 2′-O-alkyl-guanosine, cytidine, and uridine phosphoramidites
05/2001
05/29/2001US6239265 Oligonucleotides having chiral phosphorus linkages
05/23/2001EP1100805A1 Medicine nitrate salts
05/16/2001EP1099706A2 Estrane sulphamate derivatives as steroid sulphatase inhibitors
05/15/2001CA2173729C .delta.16 unsaturated c17 heterocyclic steroids useful as steroid c17-20 lyase inhibitors
05/10/2001WO2001000652A3 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS
05/10/2001US20010001099 For treatment of prostate cancer and benign prostatic hypertrophy
05/09/2001CN1294514A Steroid derived antibiotics
04/2001
04/25/2001CN1292797A Cholenic acid amides and pharmaceutical compositions thereof
04/18/2001CN1291990A S-Substituted 11 & Beta-Benzaldoxime-estra-4, 9-diene-carbonic acid thiolesters, method for production thereof and pharmaceutical preparations containing these compounds
04/11/2001EP1090027A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
04/11/2001CN1291196A Nevol anti-estrogenic steroids, and associated pharmaceutical compositions and method of use
04/05/2001DE19945385A1 New bile acid conjugates with benzylamino substituted aromatic and heteroaromatic compounds useful for prevention and treatment of gall stones
03/2001
03/29/2001WO2001021642A1 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use
03/29/2001CA2385445A1 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use
03/15/2001WO2001018025A2 17alpha propynyl 11-aryl steroids
03/15/2001WO2000066614A8 3α-HYDROXY-3β METHOXYMETHYL-21-HETEROCYCLE SUBSTITUTED STEROIDS WITH ANESTHETIC ACTIVITY
03/14/2001EP1082338A1 17 beta-nitro-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
03/14/2001EP1082337A1 17 beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
03/13/2001US6200965 Use of same to reduce plasma levels of testosterone and/or dyhydrotestosterone to treat prostate cancer and benign prostatic hypertrophy
03/07/2001EP1081157A1 Processes for the preparation of steroid derivatives, intermediates therefor and processes for the preparation of the intermediates
03/07/2001CN1286694A Novel 19-norsteroids substd in position 11 'beta', preparation method and intermediates, application as medicines and pharmaceutical compositions contg. them
03/07/2001CN1286693A 11 'beta'-halogen-7 'alpha'-substd estratrienes, method for producing pharmaceutical preparations contg. said 11 'beta'-halogen-7 'alpha'-substd estratrienes and use of same for producing medicaments
02/2001
02/28/2001EP1077992A1 Meiosis regulating compounds
02/28/2001EP0429611B1 Aminoalkyl maleimides and haptene and antigen derivatives thereof and conjugates with peptides or proteins
02/28/2001CN1062562C Corticosteroid 17-alkyl carbonate 21-[0]-carboxylic and carbonic esters, processes for their preparation, and pharmaceuticals containing these compounds
02/14/2001EP0643071B1 Compound for inhibiting bone resorption and accelerating osteogenesis
02/01/2001WO2001007462A1 11β-ARYL-17,17-SPIROTHIOLANE-SUBSTITUTED STEROIDS
01/2001
01/30/2001US6180618 Propanolamine derivatives linked to bile acids, processes for their preparation, pharmaceuticals comprising these compounds, and their use
01/25/2001WO2001005364A1 Nitrogen-containing steroid compounds and their use to regulate hair growth
01/24/2001CN1061052C 11 Beta-aromatic group-4-estraene and acid additive salt application in medicine
01/23/2001US6177447 Therapy for gaucher's disease
01/11/2001WO2001081364A1 Estra-1,3,5(10)-triene derivatives
01/09/2001US6172049 Supplying macromolecules to cells
01/04/2001WO2001000652A2 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS
12/2000
12/28/2000WO2000078789A1 Aromatic and heterocyclic derivatives of phytosterols and/or phytostanols for use in treating or preventing cardiovascular disease
12/28/2000DE19929715A1 New 11-beta-long chain substituted estratriene derivatives, are antiestrogens or tissue-selective partial estrogens useful e.g. for treating hormone-dependent cancer or osteoporosis
12/28/2000CA2376733A1 Aromatic and heterocyclic derivatives of phytosterols and/or phytostanols for use in treating or preventing cardiovascular disease
12/27/2000EP0716604A4 Thiol-derivatized nucleosides and oligonucleosides
12/26/2000US6166199 Contacting purine with amino, hydrazine, hydroxylamine, thiol, semicarbazide, thiosemicarbazide, hydrazone, hydrazide, imidazole, tetrazole, triazole, pyrrolidine, piperidine, piperazine, morpholine, aldehyde, ketone, alcohol; antisense
12/20/2000EP1060188A1 Cholenic acid amides and pharmaceutical compositions thereof
12/20/2000EP1060187A1 S-substituted 11beta-benzaldoxime-estra-4,9-diene-carbonic acid thiolesters, method for the production thereof and pharmaceutical preparations containing these compounds
12/20/2000EP1060186A1 20-keto-11beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
12/13/2000EP1058552A1 Steroid derived antibiotics
12/13/2000CN1059446C Pharmaceutical composition and compounds for contraception, and their use
12/12/2000US6159960 Steroid sulphatase inhibitors
12/06/2000EP1056768A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
11/2000
11/09/2000WO2000066614A1 3α-HYDROXY-3β METHOXYMETHYL-21-HETEROCYCLE SUBSTITUTED STEROIDS WITH ANESTHETIC ACTIVITY
11/09/2000CA2372342A1 3.alpha.-hydroxy-3.beta. methoxymethyl-21-heterocycle substituted steroids with anesthetic activity
11/08/2000EP0650495B1 Improved antiandrogens
11/07/2000US6143736 Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
11/01/2000CN1271734A Substituted 19-norsteroid, its preparation and intermediate and its medical use and composition
10/2000
10/17/2000US6133438 Alkylating unblocked cytidine to form 2'-o-alkylated cytidine, blocking the 5'-hydroxyl moiety, and phosphitylating the 3'-position
10/17/2000US6133280 Androgen synthesis inhibitors
10/11/2000EP1042355A1 11beta-halogen-7alpha-substituted estratrienes, method for producing pharmaceutical preparations containing said 11beta-halogen-7alpha-substituted estratrienes and use of the same for producing medicaments
10/11/2000CN1057305C Estra-1,3,5(10)-triene derivatives, methods of preparing such compounds and pharmaceuticals
09/2000
09/28/2000WO2000056759A1 Processes for the preparation of steroid derivatives, intermediates therefor and processes for the preparation of the intermediates
09/27/2000EP1038880A2 Androstanes and pregnanes for allosteric modulation of GABA receptor
09/06/2000EP1032584A1 Novel 19-nor steroids substituted in position 11beta, preparation method and intermediates, application as medicines and pharmaceutical compositions containing them
09/06/2000CN1056151C 17-deoxycorticosteroid-21-(O)-carboxylic esters, process for their preparation and pharmaceuticals containing these compounds
09/05/2000US6114513 Medical diagnosis; transfer across cell membranes
08/2000
08/29/2000US6110906 Androgen derivatives for use in the inhibition of sex steroid activity
08/23/2000EP0752860B1 Androstanes and pregnanes for allosteric modulation of gaba receptor
08/17/2000WO2000047604A1 Unsaturated cholestane derivatives and their use for the preparation of meiosis regulating medicaments
08/17/2000CA2359687A1 Unsaturated cholestane derivatives and their use for the preparation of meiosis regulating medicaments
08/16/2000CN1055391C Use of substituted aromatic steroids control fertility and pharmaceutical composition thereof
08/09/2000EP1025116A1 Estra-1,3,5(10)-triene-7alpha-thioethers
08/02/2000EP1024146A1 The use of steroid saponin compounds to prevent senility, and novel steroid saponin compounds
08/02/2000EP1023316A2 Methods and compositions for lipidization of hydrophilic molecules
08/02/2000EP1023315A1 Methods and compositions for destruction of selected proteins
08/02/2000EP0721956B1 21-substituted steroid compound
07/2000
07/26/2000CN1054856C New 19-nor steroids having phenoxyalkylsulphonemide or phenoxyalkylsulphonylurea chain in position llbeta, preparation process and intermediates, use as medicaments and pharmaceutical
07/25/2000US6093707 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
07/19/2000EP1019365A1 Novel compositions for the delivery of negatively charged molecules
07/19/2000EP1019095A1 Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 26